A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II
Summary
- Eligibility
- for males (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Paul Harmatz
Description
Summary
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Paul Harmatz
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 205 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- ID
- NCT04573023
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 80 study participants
- Last Updated